Beyond Meat (NASDAQ:BYND) completed an initial public offering (IPO) in May raising $240 million at a valuation of about $1.5 billion.
Read more here.
![[CytoReason in Israel Hayom] Israel’s CytoReason, S. Korea’s Helixrus partner on machine learning for drug development](https://blog.ourcrowd.com/wp-content/themes/Extra/images/post-format-thumb-text.svg)
[CytoReason in Israel Hayom] Israel’s CytoReason, S. Korea’s Helixrus partner on machine learning for drug development
April 12, 2022
[IQM in WAM] Investment in quantum computing to be major economic driving force in next two years: experts at Investopia 2023
March 5, 2023
